# Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs

> **NCT07589322** · NA · RECRUITING · sponsor: **Tri-Service General Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Obesity and Metabolic Syndrome

## Interventions

- **DRUG:** Tirzepatide with lifestyle modification
- **DRUG:** Semaglutide with lifestyle modification

## Key facts

- **NCT ID:** NCT07589322
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07589322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07589322, "Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT07589322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*